XIAOMI-W
01810
BABA-W
09988
MIXUE GROUP
02097
4
TENCENT
00700
5
CKH HOLDINGS
00001
HK Stock MarketDetailed Quotes
01681 CONSUN PHARMA
- 7.690
- +0.010+0.13%
Market Closed Mar 5 17:53 CST
6.53BMarket Cap7.13P/E (TTM)
7.850High7.650Low1.60MVolume7.710Open7.680Pre Close12.38MTurnover0.19%Turnover Ratio7.55P/E (Static)849.51MShares8.88052wk High1.61P/B6.53BFloat Cap4.45052wk Low0.90Dividend TTM849.51MShs Float8.880Historical High0.441Dividend LFY2.60%Amplitude0.580Historical Low7.719Avg Price1000Lot Size11.64%Div YieldTTM5.73%Div Yield LFY
CONSUN PHARMA Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 13.30%1.27B | 10.71%2.59B | 12.70%1.12B | 14.43%2.34B | 12.07%993.53M | 16.65%2.04B | 15.76%886.53M | 1.42%1.75B | -18.62%765.86M | -6.28%1.73B |
| Operating income | 13.30%1.27B | 10.71%2.59B | 12.70%1.12B | 14.43%2.34B | 12.07%993.53M | 16.65%2.04B | 15.76%886.53M | 1.42%1.75B | -18.62%765.86M | -6.28%1.73B |
| Cost of sales | -13.33%-321.03M | -15.90%-668.44M | -10.89%-283.26M | -11.48%-576.74M | -13.38%-255.44M | -19.98%-517.32M | -15.97%-225.29M | 7.65%-431.16M | 23.49%-194.27M | -1.59%-466.85M |
| Operating expenses | -13.33%-321.03M | -15.90%-668.44M | -10.89%-283.26M | -11.48%-576.74M | -13.38%-255.44M | -19.98%-517.32M | -15.97%-225.29M | 7.65%-431.16M | 23.49%-194.27M | -1.59%-466.85M |
| Gross profit | 13.28%947.52M | 9.01%1.92B | 13.32%836.42M | 15.42%1.76B | 11.62%738.09M | 15.56%1.53B | 15.68%661.24M | 4.78%1.32B | -16.82%571.59M | -8.89%1.26B |
| Selling expenses | -13.78%-411.91M | -10.40%-852.21M | -10.57%-362.03M | -24.50%-771.96M | -18.28%-327.42M | -14.20%-620.04M | -23.55%-276.81M | -0.69%-542.93M | 18.32%-224.04M | 3.98%-539.2M |
| Administrative expenses | 1.49%-134.71M | 2.14%-315.6M | -1.07%-136.74M | -15.20%-322.5M | -31.87%-135.3M | -37.86%-279.96M | -16.87%-102.6M | -25.75%-203.07M | -8.66%-87.79M | 8.52%-161.49M |
| Impairment and provision | -47.69%9.17M | -61.23%12.6M | 37.08%17.53M | 80.09%32.49M | 850.22%12.79M | 161.45%18.04M | 109.28%1.35M | 92.59%-29.36M | -48.67%-14.51M | ---396.48M |
| -Goodwill impairment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---326.14M |
| -Other impairment is provision | -47.69%9.17M | -61.23%12.6M | 37.08%17.53M | 80.09%32.49M | 850.22%12.79M | 161.45%18.04M | 109.28%1.35M | 58.26%-29.36M | -48.67%-14.51M | ---70.35M |
| Special items of operating profit | 25.74%37.26M | 110.16%118.5M | 16.44%29.63M | -11.04%56.39M | -14.47%25.45M | 7.75%63.38M | 144.70%29.76M | 3,954.91%58.83M | 1,489.83%12.16M | 30.45%-1.53M |
| Operating profit | 16.25%447.33M | 16.85%884.97M | 22.70%384.81M | 6.85%757.33M | 0.22%313.61M | 17.12%708.77M | 21.57%312.93M | 271.92%605.14M | -19.92%257.41M | -74.74%162.71M |
| Financing cost | -85.58%-13.38M | -94.49%-21.26M | -76.04%-7.21M | 15.28%-10.93M | 21.89%-4.09M | 39.70%-12.91M | 54.40%-5.24M | 26.31%-21.4M | 0.23%-11.49M | -5.73%-29.04M |
| Earning before tax | 14.92%433.96M | 15.72%863.7M | 22.00%377.61M | 7.26%746.39M | 0.59%309.52M | 19.21%695.86M | 25.12%307.69M | 336.72%583.74M | -20.65%245.92M | -78.33%133.66M |
| Tax | -10.82%-33M | -23.05%-77.15M | -114.56%-29.78M | 42.35%-62.7M | 77.90%-13.88M | -6.62%-108.74M | -28.91%-62.79M | -44.59%-101.99M | 2.55%-48.7M | 40.83%-70.54M |
| After-tax profit from continuing operations | 15.27%400.96M | 15.04%786.55M | 17.65%347.83M | 16.45%683.7M | 20.72%295.64M | 21.87%587.12M | 24.18%244.91M | 663.19%481.74M | -24.13%197.21M | -87.31%63.12M |
| Earning after tax | 15.27%400.96M | 15.04%786.55M | 17.65%347.83M | 16.45%683.7M | 20.72%295.64M | 21.87%587.12M | 24.18%244.91M | 663.19%481.74M | -24.13%197.21M | -87.31%63.12M |
| Minority profit | 1,967.19%1.2M | 155.70%2.02M | 94.12%-64K | 125.86%790K | 81.02%-1.09M | 82.08%-3.06M | 50.84%-5.74M | -2.08%-17.05M | -211.44%-11.67M | -151.96%-16.7M |
| Profit attributable to shareholders | 14.91%399.77M | 14.88%784.53M | 17.24%347.89M | 15.71%682.91M | 18.39%296.73M | 18.32%590.17M | 19.99%250.64M | 524.89%498.79M | -16.27%208.89M | -82.85%79.82M |
| Basic earnings per share | 13.14%0.4987 | 15.12%0.99 | 17.77%0.4408 | 16.22%0.86 | 19.51%0.3743 | 21.31%0.74 | 23.94%0.3132 | 577.78%0.61 | -13.72%0.2527 | -83.47%0.09 |
| Diluted earnings per share | 12.89%0.493 | 13.95%0.98 | 16.98%0.4367 | 17.81%0.86 | 19.76%0.3733 | 19.67%0.73 | 23.35%0.3117 | 577.78%0.61 | -12.01%0.2527 | -83.02%0.09 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | KPMG | -- | KPMG | -- | KPMG | -- | KPMG | -- | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.